This site uses cookies to collect activity data and personalize content. By continuing to navigate this site, you agree to allow us to collect information using cookies. Learn more about how we care for your data in our privacy notice.

Accept

Review of the current published evidence for single-dose HPV vaccination

The primary objective of this review is to summarize and assess the current evidence that could support a change to a single-dose schedule of HPV vaccine. The review also aims to identify gaps that remain in determining whether a single dose could be sufficiently protective to have a major impact against HPV infection and its sequelae, within the context of immunization programs.

Corporate author(s): Single-Dose HPV Vaccine Evaluation Consortium

Publication date: May 2022

Available materials

    1. Single-Dose HPV Vaccine Evaluation Consortium Statement 387.4 KB PDF
    2. Single-Dose HPV Vaccine Evaluation Consortium Evidence Review (Fourth Edition - May 2022) 2.6 MB PDF
    3. Single-Dose HPV Vaccine Evaluation Consortium Evidence Review (Third Edition - November 2020) 2.9 MB PDF
    4. Single-Dose HPV Vaccine Evaluation Consortium White Paper (Second Edition - June 2019) 3.9 MB PDF
    5. Single-Dose HPV Vaccine Evaluation Consortium White Paper (First Edition - April 2018) 6.3 MB PDF